LivsMed

리브스메드 · 491000

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$868.8M (₩1.2T)

Overview

LivsMed develops and manufactures articulating surgical instruments used in minimally invasive (laparoscopic) surgery, procedures performed through small incisions using a camera and slim tools, avoiding the need to open the body fully.

Its instruments are used by surgeons in hospitals and are cleared for use in major markets including the United States, Europe, and Japan. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company's product range centres on its ArtiSential articulating laparoscopic instrument, alongside a vascular stapler, a surgical stapler, a camera system, and a surgical robot, all built around a shared multi-joint end-tool technology.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$37.1M
Operating profit · FY2025
−US$16.4M
Net income · FY2025
−US$16.6M

Revenue

  • FY2025US$37.1M

Operating profit

  • FY2025−US$16.4M

Net income

  • FY2025−US$16.6M

Key ratios (FY2025)

ROE
-12.7%
Debt/Eq
11.7%
Op. margin
-44.2%
Net margin
-44.7%
Rev. YoY
N/A (see filing)

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.